北京大学血液病研究所造血干细胞移植北京市重点实验室.pptVIP

Huang XJ, et al. BMT, 2006, 38:291 Huang XJ, et al. Blood, 2006, 107(8):3065-3073 Huang XJ, et al. Clin Cancer Res, 2009, 15: 4777-4783 Huang XJ, et al. BBMT. 2011 Feb;17(2):197-204 Part I Conclusions G-BM combined with PBSC from haploidentical family donors, without in vitro TCD, may be used as a good source of stem cells for allo-HSCT There is no difference in OS and LFS between patients receiving allografts from PMRD and URD 3. Unmanipulated Haploidentical HSCT 3.Unmanipulated Haploidentical HSCT Huang XJ, et al Unpublished，Blood Reversed Part II：Strategy to Improve the Clinical Result